1. Home
  2. OCFC vs EVO Comparison

OCFC vs EVO Comparison

Compare OCFC & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OceanFirst Financial Corp.

OCFC

OceanFirst Financial Corp.

HOLD

Current Price

$18.15

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.63

Market Cap

994.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OCFC
EVO
Founded
1902
1993
Country
United States
Germany
Employees
1007
4553
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
994.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
OCFC
EVO
Price
$18.15
$2.63
Analyst Decision
Buy
Strong Buy
Analyst Count
3
1
Target Price
$21.67
$7.00
AVG Volume (30 Days)
1.1M
29.1K
Earning Date
04-23-2026
04-08-2026
Dividend Yield
4.24%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$47.51
$1.37
Revenue Next Year
$21.97
$10.05
P/E Ratio
$16.71
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.09
$2.31
52 Week High
$20.61
$4.42

Technical Indicators

Market Signals
Indicator
OCFC
EVO
Relative Strength Index (RSI) 46.99 42.35
Support Level $17.29 $2.63
Resistance Level $18.62 $3.75
Average True Range (ATR) 0.44 0.07
MACD 0.00 -0.02
Stochastic Oscillator 55.93 20.72

Price Performance

Historical Comparison
OCFC
EVO

About OCFC OceanFirst Financial Corp.

OceanFirst Financial Corp is engaged in the banking sector of the United States. It conducts the business of attracting retail and business deposits and investing them in loans, consisting of single-family, owner-occupied residential mortgage loans, and commercial real estate loans. The company's sole segment deals with the delivery of loan and deposit products to customers. The bank's revenues are derived principally from interest on its loans, and to a lesser extent, interest on its investment and mortgage-backed securities. The rest of its income is dependent on bank card services and wealth management products and services.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: